Scale-Up Considerations Based on Studies at the Bench Scale in Stirred Bioreactors

2009 ◽  
Vol 42 (11) ◽  
pp. 789-796 ◽  
Author(s):  
Alvin William Nienow
2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Pouria Fattahi ◽  
Ali Rahimian ◽  
Michael Q. Slama ◽  
Kihak Gwon ◽  
Alan M. Gonzalez-Suarez ◽  
...  

AbstractCellular therapies based on human pluripotent stem cells (hPSCs) offer considerable promise for treating numerous diseases including diabetes and end stage liver failure. Stem cell spheroids may be cultured in stirred bioreactors to scale up cell production to cell numbers relevant for use in humans. Despite significant progress in bioreactor culture of stem cells, areas for improvement remain. In this study, we demonstrate that microfluidic encapsulation of hPSCs and formation of spheroids. A co-axial droplet microfluidic device was used to fabricate 400 μm diameter capsules with a poly(ethylene glycol) hydrogel shell and an aqueous core. Spheroid formation was demonstrated for three hPSC lines to highlight broad utility of this encapsulation technology. In-capsule differentiation of stem cell spheroids into pancreatic β-cells in suspension culture was also demonstrated.


2017 ◽  
Vol 34 (2) ◽  
pp. 395-405 ◽  
Author(s):  
Ellen Cristina Souza ◽  
Thereza Christina Vessoni-Penna ◽  
Saleh Al Arni ◽  
José Manuel Domínguez ◽  
Attilio Converti ◽  
...  

Author(s):  
Roger G. Harrison ◽  
Paul W. Todd ◽  
Scott R. Rudge ◽  
Demetri P. Petrides

The development of efficient and reliable processes for bioseparations is dependent on the availability of suitable analytical methods. This means it is important that work on analytical methodology for the bioproduct of interest starts at the very beginning of process development. Analytical studies are important throughout the development and scale up of the process, as changes can occur either to the product or to its associated impurities from what may be thought of as minor changes in the process. This chapter gives access to the vocabulary and techniques used in quality control and analytical development activities, starting with a description of specifications typically set for a pharmaceutical and the rationale behind them. Then, before discussing the assays themselves, we describe assay attributes, which can be measured and used to help not only the assay developer but also the biochemist and engineer responsible for developing downstream processes determine the usefulness and meaning of the assay. Finally, we turn to assays that are commonly applied in biotechnology, as they apply to biological activity, identity, and purity. These assays are the ultimate yardsticks by which the process is measured. Purification methods are developed for their ability to remove a contaminant from the product of interest, whether it is a related molecule, a contaminant related to a host organism, such as DNA or endotoxin, or a process contaminant, such as a residual solvent or water. Critical to understanding process performance is an understanding of how the assays that measure these contaminants have been developed, what the assay strengths and limitations are, and what they indicate and why. Electrophoresis and magnetic separation are two methods that are now used for the bench scale preparative purification of bioproducts, including living cells. The electrophoresis systems with the highest capacity are free-flow electrophoresis, density gradient electrophoresis, recycling free-flow isoelectric focusing, and rotating isoelectric focusing, and the principles of operation of these are discussed. The physical principles of magnetic separations are presented, as well as magnetic reagents and applications of magnetic separators.


2006 ◽  
Vol 6 (4) ◽  
pp. 107-116
Author(s):  
T.U. Kim ◽  
C. Bellona ◽  
P. Xu ◽  
J. Drewe ◽  
G. Amy

There has been considerable information reported on rejection of trace organic compounds from pilot-scale and full-scale experiments with reverse osmosis (RO) and nanofiltration (NF), but this information has limited value in predicting the rejection of these compounds by high-pressure membranes. The goal of this research is to define relationships between compound properties, membrane properties, and operational conditions, e.g. pressure, recovery, affecting trace organic compound rejection, comparing bench-scale recirculation tests and bench-scale single-pass tests. In addition, bench-scale results are compared against single element tests to ascertain scale-up effects.


Fuel ◽  
2007 ◽  
Vol 86 (9) ◽  
pp. 1270-1277 ◽  
Author(s):  
José A.D. Muñoz ◽  
Ignacio Elizalde ◽  
Jorge Ancheyta

2011 ◽  
Vol 27 (5) ◽  
pp. 1421-1432 ◽  
Author(s):  
Ana Fernandes-Platzgummer ◽  
Maria M. Diogo ◽  
Ricardo P. Baptista ◽  
Cláudia Lobato da Silva ◽  
Joaquim M.S. Cabral

Catalysts ◽  
2019 ◽  
Vol 9 (2) ◽  
pp. 186 ◽  
Author(s):  
Sanggil Moon ◽  
Ho-Jeong Chae ◽  
Min Park

Bioethanol dehydration was carried out in a bench scale reactor-loaded H-ZSM-5 molded catalyst, which increased by tens of times more than at lab scale (up to 60 and 24 times based on the amount of catalyst and ethanol flow rate, respectively). From the results of the lab scale reaction, we confirmed the optimum Si/Al ratio (14) of H-ZSM-5, reaction temperature (~250 °C), and weight hourly space velocity (WHSV) (<5 h−1) indicating high ethanol conversion and ethylene selectivity. Five types of cylindrical shaped molded catalysts were prepared by changing the type and/or amount of organic solid binder, inorganic solid binder, inorganic liquid binder, and H-ZSM-5 basis catalyst. Among them, the catalyst exhibiting the highest compression strength and good ethanol dehydration performance was selected. The bench scale reaction with varying reaction temperature of 245–260 °C and 1.2– 2.0 h−1 WHSV according to reaction time showed that the conversion and ethylene selectivity were more than 90% after 400 h on stream. It was also confirmed that even after the successive catalyst regeneration and the reaction for another 400 h, both the ethanol conversion and ethylene selectivity were still maintained at about 90%.


2016 ◽  
Vol 2016 ◽  
pp. 1-15 ◽  
Author(s):  
Valentin Jossen ◽  
Cedric Schirmer ◽  
Dolman Mostafa Sindi ◽  
Regine Eibl ◽  
Matthias Kraume ◽  
...  

The potential of human mesenchymal stem cells (hMSCs) for allogeneic cell therapies has created a large amount of interest. However, this presupposes the availability of efficient scale-up procedures. Promising results have been reported for stirred bioreactors that operate with microcarriers. Recent publications focusing on microcarrier-based stirred bioreactors have demonstrated the successful use of Computational Fluid Dynamics (CFD) and suspension criteria (NS1u,NS1) for rapidly scaling up hMSC expansions from mL- to pilot scale. Nevertheless, one obstacle may be the formation of large microcarrier-cell-aggregates, which may result in mass transfer limitations and inhomogeneous distributions of stem cells in the culture broth. The dependence of microcarrier-cell-aggregate formation on impeller speed and shear stress levels was investigated for human adipose derived stromal/stem cells (hASCs) at the spinner scale by recording the Sauter mean diameter (d32) versus time. Cultivation at the suspension criteria providedd32values between 0.2 and 0.7 mm, the highest cell densities (1.25 × 106cells mL−1hASCs), and the highest expansion factors (117.0 ± 4.7 on day 7), while maintaining the expression of specific surface markers. Furthermore, suitability of the suspension criterionNS1uwas investigated for scaling up microcarrier-based processes in wave-mixed bioreactors for the first time.


Sign in / Sign up

Export Citation Format

Share Document